Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
August 31, 2009

Novartis to Exploit Nuevolution Platform for Drug Discovery

  • Novartis enlisted the help of Danish drug discovery company Nuevolution to identify small molecule leads against specific drug targets. Nuevolution will use its fragment-based drug screening platform called Chemetics®. The company says this technology combines proven wet chemistry and molecular biology to allow the rapid synthesis and selection of ligands from potentially billions of drug-like compounds in a single test tube.  The companies will work together to carry out hit-to-lead optimization.


","DownloadsUrl":"","CompanyUrl":null,"CompanyEmail":null,"IsFavoriteItem":false,"RequestRawUrl":"/gen-news-highlights/p-novartis-to-exploit-nuevolution-platform-for-drug-discovery-p/78565138?kwrd=Lead%20Optimization","HasIssueInfo":false,"IssueInfo":null}; var isAuthenticated = 'False';

Related content

  • You’re all set! Thank you for subscribing to GEN Highlights.